Neuromedin U and Structural Analogs: An Overview of their Structure, Function and Selectivity

Author(s): An De Prins, Ann Van Eeckhaut*, Ilse Smolders*, Dirk Tourwé, Steven Ballet*

Journal Name: Current Medicinal Chemistry

Volume 27 , Issue 39 , 2020

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor

Abstract:

The neuromedin U peptide sequence is highly conserved between various species. Neuromedin U is involved in a variety of physiological processes. It exerts its effects via two neuromedin U receptors, NMUR1 and NMUR2. These receptors are characterized by a distinct, yet complementary, tissue distribution with NMUR1 mostly found in the periphery, while NMUR2 is most abundant in the central nervous system. The capability of the neuropeptide to reduce food intake in rodents triggered the design and synthesis of a broad range of modified peptide ligands. The purpose of these ligands is to develop novel therapeutics which could be beneficial in the treatment of obesity and diabetes. Most compounds are derived either from the full-length neuromedin U sequence or are based on the truncated orthologs of this neuropeptide. Only a few non-peptidic ligands were developed. This review provides an overview on various neuromedin U analogs and mimetics that have been reported to date.

Keywords: Neuromedin U, neuromedin U receptor 1, neuromedin U receptor 2, agonist, antagonist, analog, peptidomimetic.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 27
ISSUE: 39
Year: 2020
Published on: 24 November, 2020
Page: [6744 - 6768]
Pages: 25
DOI: 10.2174/0929867326666190916143028
Price: $65

Article Metrics

PDF: 40